Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus With Diabetic Nephropathy”

204 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 204 results

Early research (Phase 1)Study completedNCT00754143
What this trial is testing

Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy

Who this might be right for
Diabetes MellitusDiabetic Nephropathy
Kyntra Bio 38
Testing effectiveness (Phase 2)Study completedNCT00097955
What this trial is testing

Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria

Who this might be right for
Diabetic Nephropathy
Novartis Pharmaceuticals 496
Testing effectiveness (Phase 2)Study completedNCT02316821
What this trial is testing

The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Kyowa Kirin Co., Ltd. 216
Not applicableStudy completedNCT00364988
What this trial is testing

Pioglitazone and Losartan Provides Additional Renoprotection

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Shanghai Jiao Tong University School of Medicine 60
Not applicableStudy completedNCT05631119
What this trial is testing

Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes

Who this might be right for
Diabetic Kidney DiseaseDiabetes Type 2Chronic Kidney Diseases+1 more
Sanguine Biosciences 40
Testing effectiveness (Phase 2)Study completedNCT01667614
What this trial is testing

Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure

Who this might be right for
Type 2 Diabetes MellitusDiabetic NephropathyEssential Hypertension
Tehran University of Medical Sciences 136
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07325201
What this trial is testing

Reducing Risk of Diabetic Ketoacidosis in Type 1 Diabetes and Kidney Disease Using Continuous Ketone Monitoring

Who this might be right for
Type 1 Diabetes MellitusChronic Kidney Disease (CKD) With Diabetes Mellitus (DM)Chronic Kidney Disease
HealthPartners Institute 80
Post-approval studies (Phase 4)Study completedNCT00234871
What this trial is testing

Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)

Who this might be right for
HypertensionDiabetesProteinuria
Abbott 357
Not applicableStudy completedNCT04931030
What this trial is testing

Low Carbohydrate Diet in Diabetic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney DiseaseObesity
Universiti Teknologi Mara 30
Testing effectiveness (Phase 2)Study completedNCT01874431
What this trial is testing

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathies
Bayer 823
Testing effectiveness (Phase 2)Study completedNCT00287183
What this trial is testing

6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria

Who this might be right for
Diabetic Nephropathy
Pfizer 110
Not applicableStudy completedNCT00324675
What this trial is testing

Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy

Who this might be right for
Type 2 DiabetesOvert Diabetic Nephropathy
Technische Universität Dresden 28
Testing effectiveness (Phase 2)WithdrawnNCT04661917
What this trial is testing

A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.

Who this might be right for
Chronic Kidney DiseaseDiabetic Kidney Disease
Bayer
Large-scale testing (Phase 3)Ended earlyNCT04741074
What this trial is testing

Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy

Who this might be right for
CKDDiabetic Kidney DiseaseType 2 Diabetes Mellitus in Obese+2 more
Geisinger Clinic 15
Not applicableEnrolling By InvitationNCT07038213
What this trial is testing

Study of Genome-associated Mechanisms of Diabetic Nephropathy and Evaluation of Nephroprotective Therapy in Patients With Type 2 Diabetes Mellitus in the Kazakh Population

Who this might be right for
Diabetes MellitusDiabetic Nephropathy
Astana Medical University 100
Testing effectiveness (Phase 2)Ended earlyNCT01752985
What this trial is testing

Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Bristol-Myers Squibb 319
Post-approval studies (Phase 4)Study completedNCT06326034
What this trial is testing

Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients

Who this might be right for
Diabetic Nephropathy Type 2
Mohammed Mahmood Mohammed 40
Large-scale testing (Phase 3)Study completedNCT01316094
What this trial is testing

Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Inc 165
Large-scale testing (Phase 3)Study completedNCT00141453
What this trial is testing

ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial

Who this might be right for
Diabetic NephropathyType 2 Diabetes MellitusProteinuria
Daiichi Sankyo Co., Ltd. 577
Testing effectiveness (Phase 2)Study completedNCT01200394
What this trial is testing

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

Who this might be right for
Diabetic Nephropathies
Pfizer 256
Load More Results